- Home
- RNAC vs OSUR Comparison
RNAC vs OSUR Comparison
Compare RNAC & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAC
- OSUR
- Stock Information
- Founded
- RNAC 2007
- OSUR 2000
- Country
- RNAC United States
- OSUR United States
- Employees
- RNAC N/A
- OSUR N/A
- Industry
- RNAC Biotechnology: Pharmaceutical Preparations
- OSUR Medical/Dental Instruments
- Sector
- RNAC Health Care
- OSUR Health Care
- Exchange
- RNAC Nasdaq
- OSUR Nasdaq
- Market Cap
- RNAC 204.6M
- OSUR 177.2M
- IPO Year
- RNAC 2016
- OSUR 1986
- Fundamental
- Price
- RNAC $7.49
- OSUR $2.31
- Analyst Decision
- RNAC Strong Buy
- OSUR Hold
- Analyst Count
- RNAC 4
- OSUR 2
- Target Price
- RNAC $40.50
- OSUR $3.00
- AVG Volume (30 Days)
- RNAC 154.5K
- OSUR 569.3K
- Earning Date
- RNAC 11-06-2025
- OSUR 11-05-2025
- Dividend Yield
- RNAC N/A
- OSUR N/A
- EPS Growth
- RNAC N/A
- OSUR N/A
- EPS
- RNAC N/A
- OSUR N/A
- Revenue
- RNAC $1,091,000.00
- OSUR $125,703,000.00
- Revenue This Year
- RNAC N/A
- OSUR N/A
- Revenue Next Year
- RNAC N/A
- OSUR $4.32
- P/E Ratio
- RNAC N/A
- OSUR N/A
- Revenue Growth
- RNAC N/A
- OSUR N/A
- 52 Week Low
- RNAC $5.98
- OSUR $2.20
- 52 Week High
- RNAC $26.50
- OSUR $4.22
- Technical
- Relative Strength Index (RSI)
- RNAC 36.81
- OSUR 28.71
- Support Level
- RNAC $7.15
- OSUR $2.30
- Resistance Level
- RNAC $7.74
- OSUR $2.51
- Average True Range (ATR)
- RNAC 0.66
- OSUR 0.11
- MACD
- RNAC -0.02
- OSUR -0.03
- Stochastic Oscillator
- RNAC 50.87
- OSUR 15.97
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.